Katarina Chalupova Selected Research

BP-1-102

12/2021

Design, synthesis, and in vitro evaluation of BP-1-102 analogs with modified hydrophobic fragments for STAT3 inhibition.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katarina Chalupova Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2019
2	Amnesia (Dissociative Amnesia) 01/2021 - 04/2019
1	Neoplasms (Cancer) 12/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2021

Drug/Important Bio-Agent (IBA)

2	Tryptophan (L-Tryptophan)FDA Link 01/2021 - 04/2019
2	Tacrine (Cognex)FDA Link 01/2021 - 04/2019
2	Scopolamine (Hyoscine)FDA Link 01/2021 - 04/2019
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2019
1	BP-1-102IBA 12/2021
1	Cytotoxins (Cytolysins)IBA 12/2021
1	benzothiazoleIBA 01/2021
1	AcetylcholinesteraseIBA 01/2021
1	EnzymesIBA 01/2021
1	huprine YIBA 01/2021
1	LigandsIBA 04/2019
1	Donepezil (Aricept)FDA LinkGeneric 01/2019

Therapy/Procedure

1	Therapeutics 01/2021